EOD Prostate Pathologic Extension

This input is used for staging


**Note 1:** Only use histologic information from a radical prostatectomy and/or autopsy in this field. Information from biopsy of extraprostatic sites is coded in EOD Primary Tumor. * Code results from a transurethral resection of prostate (TURP) or simple prostatectomy in EOD Primary Tumor **Note 2:** Code 900 if there is no radical prostatectomy or autopsy performed within first course of treatment. (See also Note 7) * A radical prostatectomy is defined as Surgery of Primary Site codes 50-70 * If Surgery of primary site is 00-30, 90, then code 900 * *Note:* Surgery of primary site can be 00 if an autopsy is done **Note 3:** Limit information in this field to first course of treatment in the absence of disease progression. **Note 4:** When prostate cancer is an incidental finding during a prostatectomy for other reasons (for example, a cystoprostatectomy for bladder cancer), or an autopsy, use the appropriate code for the extent of disease found. **Note 5:** Involvement of the prostatic urethra does not alter the extension code. **Note 6:** "Frozen pelvis" is a clinical term which means tumor extends to pelvic sidewall(s). In the absence of a more detailed statement of involvement, assign this to code 700. **Note 7:** Code 950 is used when first course of treatment is active surveillance, but a radical prostatectomy is done at a later date due to disease progression or the patient changed their mind. * When code 950 is used, code the following SSDIs as X9: Gleason Patterns Pathological, Gleason Score Pathological, and Gleason Tertiary, **Note 8:** Code 999 when * Radical prostatectomy is performed, but there is no information on the extension * Surgery of Primary Site is Prostatectomy, NOS (Surgery of Primary Site is 80) * Unknown if surgery is done (Surgery of Primary Site is 99)




NAACCR #3919
Code Description SS2018 T
000 In situ: noninvasive; intraepithelial IS
300 Invasion into (but not beyond) prostatic capsule Intracapsular involvement only No extracapsular extension Confined to prostate, NOS Localized, NOS L
350 Bladder neck, microscopic invasion Extraprostatic extension (beyond prostatic capsule), unilateral, bilateral, or NOS WITHOUT invasion of the seminal vesicles Extension to periprostatic tissue WITHOUT invasion of the seminal vesicles RE
400 Tumor invades seminal vesicle(s) RE
500 Extraprostatic tumor that is not fixed WITHOUT invasion of adjacent structures Periprostatic extension, NOS (unknown if seminal vesicle(s) involved) Extraprostatic extension, NOS (unknown if seminal vesicle(s) involved) Through capsule, NOS RE
600 Bladder neck, except microscopic bladder neck involvement Bladder, NOS External sphincter Extraprostatic urethra (membranous urethra) Fixation, NOS Levator muscles Rectovesical (Denonvillier's) fascia Rectum Skeletal muscle Ureter(s) RE
700 Extension to or fixation to pelvic wall or pelvic bone "Frozen pelvis", NOS Further contiguous extension including - Other organs - Penis - Sigmoid colon - Soft tissue other than periprostatic D
800 No evidence of primary tumor U
900 No radical prostatectomy or autopsy performed U
950 Radical prostatectomy performed, but not first course of treatment for example performed after disease progression U
999 Unknown; extension not stated Unknown if radical prostatectomy done Primary tumor cannot be assessed Not documented in medical record U
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (5) Buyyounouski, M.K., Lin, D.W., et al. **Prostate**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017